PNC Financial Services Corp., one of the largest bank holding companies in the U.S., has chosen Denver as its fifth office location for its debt capital markets team. "We carefully selected the Denver market mainly due to its impressive economy, entrepreneurial spirit and potential for additional growth," Ryan Beiser, PNC Bank's Denver market president, told Denver Business Journal.
Booz Allen Hamilton, a major defense and government technology consultancy, has opened an office in Aurora and plans to grow there as part of a larger push into space industries. The McLean, Virginia-based company has expanded its office footprint and is hiring for 20 to 30 advanced data science, intelligence analysis, agile software development and similar positions. Booz Allen Hamilton has had people in the Denver area for years but now expects to establish a staff about 200 here.
After the current trade war subsides, we will return to a more rational basis where nations and regions trade based upon comparative advantage. Everyone will produce what they produce best, and we all win by trading. There will be some manufacturing realignment with higher-value strategic manufacturing returning to the U.S. and some manufacturing moving from China to other Asian and, hopefully, Central American nations.
The Trump administration is considering scaling back intellectual-property protections for big drug makers to help win Democratic support for a new trade pact with Mexico and Canada, according to people familiar with the matter. Many Democrats, backed by labor unions and consumer groups, are pushing the administration to reduce the length of time that leading biologic drugs would be protected from generic imitators in the U.S.-Mexico-Canada Agreement, or USMCA.
Recently, a remarkable thing happened in the fight against Alzheimer's, the chronic neurodegenerative disease that accounts for a large majority of dementia cases. A woman with a genetic predisposition to acquire the condition also had another secret hidden in her genes: a protective mutation that, if scientists can replicate its mechanism of action, could lead to a drug that provides others the same protection.
